Meeting the challenge of Antimicrobial Resistance (AMR)

Breakthroughs - A podcast by Pfizer

Dr Ellie Cannon is joined by economist Lord Jim O’Neill (who in 2014 was commissioned to chair a review into the rising increase in drug-resistant infections) and Toby Cousens, Hospital and Internal Medicines Lead at Pfizer UK, to discuss the threat of antimicrobial resistance (AMR) and the challenges it poses both to science and wider society. PP-UNP-GBR-4716 / May 2023